Florian Marks
Impact in
- Endocrinology top 0.5%
- Vibrio bacteria research studies
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Viral gastroenteritis research and epidemiology 24
-
- Vibrio bacteria research studies 41
- Co-authors
- Jérôme H. Kim (20 shared papers)John D Clemens (12 shared papers)Justin Im (34 shared papers)Jürgen May (30 shared papers)Stephen Baker (12 shared papers)Christian G. Meyer (16 shared papers)Gi Deok Pak (14 shared papers)Yaw Adu‐Sarkodie (22 shared papers)
- Journals
- Clinical Infectious Diseases (26 papers)PLoS neglected tropical diseases (10 papers)BMC Infectious Diseases (8 papers)PLoS ONE (6 papers)International Journal of Infectious Diseases (5 papers)
- Partner nations
- South KoreaGermanyUnited Kingdom
In The Last Decade
Florian Marks
115 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Endocrinology 594
- Molecular Medicine 313
- Infectious Diseases 1.1k
- Applied Microbiology and Biotechnology 111
- Food Science 865
Countries citing papers authored by Florian Marks
This map shows the geographic impact of Florian Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Marks more than expected).
Fields of papers citing papers by Florian Marks
This network shows the impact of papers produced by Florian Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Marks. The network helps show where Florian Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Looking beyond COVID-19 vaccine phase 3 trials Hit paper breakdown → | 2021 | 417 |
| 2 | 2017 | 219 | |
| 3 | 2018 | 154 | |
| 4 | 2007 | 79 | |
| 5 | 2012 | 75 | |
| 6 | 2017 | 75 | |
| 7 | 2021 | 68 | |
| 8 | 2016 | 64 | |
| 9 | 2021 | 55 | |
| 10 | 2018 | 53 | |
| 11 | 2015 | 53 | |
| 12 | 2016 | 45 | |
| 13 | 2019 | 41 | |
| 14 | 2010 | 40 | |
| 15 | 2013 | 39 | |
| 16 | 2010 | 38 | |
| 17 | 2006 | 36 | |
| 18 | 2005 | 36 | |
| 19 | 2019 | 35 | |
| 20 | 2005 | 35 |
About Florian Marks
Florian Marks is a scholar working on Infectious Diseases, Endocrinology, Food Science, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 124 papers that have together received 2.5k indexed citations. Recurring topics across this work include Vibrio bacteria research studies (41 papers), Salmonella and Campylobacter epidemiology (41 papers), Viral gastroenteritis research and epidemiology (24 papers), Antibiotic Resistance in Bacteria (18 papers), Mosquito-borne diseases and control (17 papers), Vaccine Coverage and Hesitancy (15 papers), Antibiotic Use and Resistance (15 papers) and Bacterial Identification and Susceptibility Testing (14 papers). The work is most often cited by research in Endocrinology (594 citations), Molecular Medicine (313 citations), Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (111 citations) and Food Science (865 citations). Florian Marks has collaborated with scholars based in South Korea, Germany and United Kingdom. Frequent co-authors include Jérôme H. Kim, John D Clemens, Justin Im, Jürgen May, Stephen Baker, Christian G. Meyer, Gi Deok Pak, Yaw Adu‐Sarkodie, Ursula Panzner and Virginia E. Pitzer. Their work appears in journals such as Clinical Infectious Diseases, PLoS neglected tropical diseases, BMC Infectious Diseases, PLoS ONE and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.